IRIS
PERRIS, Roberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 7.577
NA - Nord America 7.076
EU - Europa 4.155
SA - Sud America 1.025
AF - Africa 346
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 7
Totale 20.196
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.913
SG - Singapore 2.837
CN - Cina 2.020
VN - Vietnam 1.153
IE - Irlanda 830
BR - Brasile 818
IT - Italia 739
SE - Svezia 658
HK - Hong Kong 584
FI - Finlandia 408
TR - Turchia 373
DE - Germania 348
NL - Olanda 266
ZA - Sudafrica 264
FR - Francia 261
UA - Ucraina 232
BD - Bangladesh 138
GB - Regno Unito 123
CA - Canada 94
AR - Argentina 89
RU - Federazione Russa 75
IN - India 70
JP - Giappone 60
IQ - Iraq 50
MX - Messico 38
AT - Austria 30
KR - Corea 29
PH - Filippine 28
BE - Belgio 27
BG - Bulgaria 27
PK - Pakistan 27
CZ - Repubblica Ceca 26
EC - Ecuador 26
IR - Iran 25
MA - Marocco 23
CO - Colombia 22
VE - Venezuela 22
EE - Estonia 19
UZ - Uzbekistan 19
PL - Polonia 18
ID - Indonesia 16
CL - Cile 15
PY - Paraguay 15
TH - Thailandia 15
ES - Italia 14
TN - Tunisia 14
JO - Giordania 13
DZ - Algeria 11
NP - Nepal 11
RO - Romania 11
LB - Libano 10
MY - Malesia 10
SA - Arabia Saudita 10
AE - Emirati Arabi Uniti 9
TW - Taiwan 9
AZ - Azerbaigian 8
CH - Svizzera 8
EG - Egitto 8
LT - Lituania 8
PE - Perù 8
KZ - Kazakistan 7
AU - Australia 6
CI - Costa d'Avorio 6
IL - Israele 6
PA - Panama 6
BO - Bolivia 5
CR - Costa Rica 5
DO - Repubblica Dominicana 5
JM - Giamaica 5
UY - Uruguay 5
XK - ???statistics.table.value.countryCode.XK??? 5
BH - Bahrain 4
EU - Europa 4
KG - Kirghizistan 4
NG - Nigeria 4
OM - Oman 4
PS - Palestinian Territory 4
PT - Portogallo 4
AL - Albania 3
BY - Bielorussia 3
ET - Etiopia 3
GE - Georgia 3
HN - Honduras 3
HU - Ungheria 3
KE - Kenya 3
KW - Kuwait 3
LK - Sri Lanka 3
QA - Qatar 3
SI - Slovenia 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BW - Botswana 2
CY - Cipro 2
DK - Danimarca 2
GT - Guatemala 2
LU - Lussemburgo 2
MM - Myanmar 2
MO - Macao, regione amministrativa speciale della Cina 2
SC - Seychelles 2
SV - El Salvador 2
Totale 20.176
Salva come PNG Salva come JPEG
Città #
Singapore 1.248
San Jose 848
Dublin 830
Chandler 769
Ashburn 675
Hong Kong 559
Beijing 449
Dearborn 424
Santa Clara 413
Ho Chi Minh City 376
Izmir 330
Nanjing 272
Jacksonville 258
Dallas 254
Boardman 249
Johannesburg 247
Hanoi 243
Princeton 212
Lauterbourg 190
Wilmington 166
Ann Arbor 154
Parma 132
New York 106
Los Angeles 104
Helsinki 87
Shenyang 86
Hefei 85
Shanghai 85
Nanchang 81
San Mateo 81
Munich 77
Buffalo 74
Jinan 73
Columbus 68
São Paulo 68
Hebei 67
Tianjin 57
Sant'Ilario d'Enza 56
Haiphong 53
Tokyo 53
Da Nang 52
Kunming 52
Seattle 52
Milan 51
Jiaxing 47
Moscow 47
Bologna 46
Toronto 45
Marseille 43
Changsha 38
Stockholm 34
Düsseldorf 30
Guangzhou 30
Norwalk 28
Rio de Janeiro 28
Des Moines 27
Bremen 26
Council Bluffs 26
Brussels 25
Frankfurt am Main 25
London 24
Vienna 24
The Dalles 23
Woodbridge 23
Zhengzhou 23
Belo Horizonte 22
Houston 22
Modena 22
Atlanta 21
Biên Hòa 21
Borås 21
Falls Church 21
Turku 21
Brno 20
Florence 20
Hải Dương 20
Montreal 20
Amsterdam 19
Baghdad 19
Ningbo 19
Nuremberg 19
Hangzhou 18
Brooklyn 17
Orem 17
Porto Alegre 17
Tashkent 17
Brasília 16
Chicago 16
Haikou 16
Redondo Beach 15
Curitiba 14
Pittsburgh 14
Taizhou 14
Boston 13
Brescia 13
Can Tho 13
Fremont 13
Fuzhou 13
Mestre 13
Rome 13
Totale 12.137
Salva come PNG Salva come JPEG
Nome #
Functional interplay between NIK and c-Abl kinases limits response to Aurora inhibitors in multiple myeloma 307
MEK1/2 KINASES DISABLE THE TUMOR SUPPRESSOR FUNCTIONS OF NATIVE BCR AND ABL1 KINASES TO IMPAIR ANTICANCER DRUGS’ RESPONSIVENESS IN TKI-RESISTANT PHILADELPHIA POSITIVE LEUKEMIAS 258
MEK-INHIBITORS/ARSENIC TRIOXIDE COMBINATION THERAPY AS A NOVEL TREATMENT OPTION FOR TYROSINE KINASE INHIBITORS-RESISTANT PH+-LEUKEMIA 254
Pro-apoptotic anti-NG2/CSPG4 monoclonal antibodies for disease therapy 193
Antithetic glypican control of cancer growth and dissemination 182
A translational perspective of the malignant hematopoietic proteoglycome 181
Proteoglycans in metastasis formation and anti-neoplastic therapeutic approaches 159
Drug resistance in higly aggressive acute leukemias is controlled by de novo espressed NG2 proteoglycan acting via modulation of selected transporters 158
Aberrant expression of TfR1/CD71 in thyroid carcinomas identifies a novel potential diagnostic marker and therapeutic target 158
Prognostic role of XTP1/DEPDC1B and SDP35/DEPDC1A in high grade soft-tissue sarcomas 151
Differential distribution of aggrecan isoforms in perineuronal nets of the human cerebral cortex 146
Combinare più indizi 146
Differential microRNA expression in osteosarcoma cell with different tumorigenic behaviour 145
Differential microRNA expression in osteosarcoma cell lines with diverse metastatic potential 144
The NeoMark Project interim results: integration of heterogeneous data for prediction of oral squamous cell cancer (OSCC) recurrence. 144
Risk stratification and prediction of locoregional recurrence in patients affected by oral squamous cell carcinoma (OSCC): the Neomark Project interim results. 141
MEK-INHIBITORS/ARSENIC TRIOXIDE COMBINATION THERAPY AS A NOVEL TREATMENT OPTION FOR TYROSINE KINASE INHIBITORS-RESISTANT PH plus -LEUKEMIA 139
Antithetic roles of proteoglycans in cancer 138
Integration of clinical, histopathological, radiological and biomolecular data for prediction of oral squamous cell cancer (OSCC) recurrence: the NeoMark Project’s first report. 138
Proteoglycans as Potential Markers of the Biological Behaviour of Head and Neck Carcinomas: Interim Results of a Multicenter Italian Project. 135
Integration of clinical, histopathological, radiological and biomolecular data for prediction of oral cancer recurrence: the NeoMark Project’s first report. 131
Proteoglycan-based diversification of disease outcome in head and neck cancer patients identifies NG2/CSPG4 and syndecan-2 as unique relapse and overall survival predicting factors 131
Pro-apoptotic anti-NG2/CSPG4 antibodies and their uses for disease therapy 128
Anticorpo monoclonale per diagnosi e trattamento di tumori canini 127
Glypican and Syndecan: tumor growth regulators 125
Neurogenic potential of human mesenchymal stem cells revised by time-lapse vide-microscopy and wide scale gene expression profiling 124
Avian neural crest cell migration is diversely regulated by the two major hyaluronan-binding proteoglycans PG-M/versican and aggrecan. 124
Approaching the Proteoglycome: Molecular interactions of proteoglycans and their functional output 124
Risk stratification and prediction of locoregional recurrence in patients affected by oral squamous cell carcinoma (OSCC): the NeoMark project results. 123
Structural deciphering of the NG2/CSPG4 proteoglycan multifunctionality. 122
Molecular cloning, sequencing, tissue and developmental expression of mouse cartilage oligomeric matrix protein (COMP) 122
Amphibian neural crest cell migration on purified extracellular matrix components: a chondroitin sulfate proteoglycan inhibits locomotion on fibronectin substrates 121
Bidirectional induction of the cognate receptor-ligand alpha4/VCAM-1 pair defines a novel mechanism of tumor intravasation 121
Pro-apoptotic anti-NG2/CSPG4 antibodies and their uses for disease therapy 121
Differential microRNA expression in osteosarcoma cell lines with diverse metastatic potential. 121
Differential microRNA expression in sarcomas with diverse metastatic potential 121
a4b1/a4b7-mediated interaction of human B cell lymphomas with fibronectin involves recognition of multiple cooperating sites 120
An intimate interplay between precocious, migrating pericytes and endothelialcells governs human fetal brain angiogenesis 120
Proteoglycans as potential markers of the biological behaviour of head and neck carcinomas: Interim Results of a Multicenter Italian Project. 120
Differential approach to define MicroRNA expression patterns in osteosarcomas 120
Integration of clinical, histopathological, radiological and biomolecular data for prediction of oral squamous cell cancer (OSCC) recurrence: the NeoMark project’s interim results. 119
Evaluation of immunohistochemical and biomolecular parameters as markers of the biological behaviour of head and neck carcinomas: preliminary results of a multicenter Italian Project. 118
MMPs and angiogenesis affect the metastatic potential of a human vulvar leiomyosarcoma cell line 118
Aggrecan is expressed by radial glia in the developing human brain 117
Diversified expression of NG2/CSPG4 isoforms in glioblastoma and human foetal brain identifies pericyte subsets 117
Theranostic impact of NG2/CSPG4 proteoglycan in cancer 117
Drug resistance in highly aggressive acute leukemias is controlled by de novo, expressed NG2 proteoglycan acting via modulation of selected transporters 116
Analysis of a novel polylactosamine-containing antigen associated with colon carcinomas. 114
XHas2 activity is required during somitogenesis and precursor cell migration in Xenopus development 112
Tunneling nanotubes evoke pericyte/endothelial communication during normal and tumoral angiogenesis 111
Validation of a Novel Three-Dimensional (3D Fusion) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study 111
Analysis of tissue-bound and circulating antigens of the poly-N-lactosamine series in colon carcinomas 109
Interaction between cartilage oligomeric matrix protein and extracellular matrix protein 1 mediates endochondral bone growth 107
Blood clotting in space 107
The angiogenic asset of soft tissue sarcomas: A new tool to discover new therapeutic targets 105
Pro-apoptotic anti-NG2/CSPG4 antibodies and their uses in disease therapy 104
Tumor cell NG2 proteoglycan controls cancer progression through its interaction with host Collagen type VI 103
Paving the path for invasion: The polyedric role of LASP1 in cancer 102
A novel laminin complex is a potent ligand for human leukocytes 102
Cell origin of tumours and the persistence of cancer propagatine cells in tumour lesions 101
Improving fluorescence-based assays for the in vitro analysis of cell adhesion and migration 100
Centrifugal assay for fluorescence-based cell adhesion adapted to the analysis of ex vivo cells and capable of determining relative binding strengths 100
PRO-APOPTOTIC ANTI-NG2/CSPG4 ANTIBODIES AND THEIR USES FOR DISEASE THERAPY 99
Chondroblastoma is an osteoid-forming, but not cartilage-forming neoplasm 99
MEK1/2 regulate normal BCR and ABL1 tumor-suppressor functions to dictate ATO response in TKI-resistant Ph+ leukemia 98
Proteoglycans in the control of tumor growth and metastasis formation 98
MicroRNA expression patterns in osteosarcomas and their potential role in tumour progression 98
Attachment of tumor and normal cell lines to collagen type VI involves recognition of the globular domains 97
Expression of cartilage oligomeric matrix protein (COMP) by embryonic and adult osteoblasts 96
Pattern d’espressione di microRNAs in cellule di osteosarcoma ed il loro potenziale ruolo nella progressione tumorale 96
Laminin-10 is a primary subendothelial ligand for tumor leukocytes 96
NG2/CSPG4-collagen type VI interplays putatively involved in the microenvironmental control of tumour engraftment and local expansion 96
Blood-brain barrier alterations in the cerebral cortex in experimental autoimmune encephalomyelitis 96
Influence of Tumor Stroma on the Aggressiveness of Poorly Cohesive Gastric Carcinoma 95
Proteomic and post-proteomic characterization of keratan sulfate-glycanated isoforms of thyroglobulin and transferrin uniquely elaborated by papillary thyroid carcinoma 95
Morphogenesis-related distribution of intermediate filaments in developing human mesonephros and metanephros 95
Role of the 4ß7 integrin in the interaction of murine leukemic cells with fibronectin after the in vivo progression from a T-cell lymphoma to leukemic phenotype 95
Preferential locomotion of leukemic cells towards laminin isoforms 8, and 10 94
Localization and expression of Cartilage Oligomeric Matrix Protein (COMP) by human rheumatoid and osteoarthritic synovium and cartilage 94
Structural and compositional divergencies in the extracellular matrix encountered by neural crest cells in the white mutant axolotl embryo 94
Sonic hedgehog regulates the position of the trigeminal ganglia 93
"Destemming" cancer stem cells. 93
MicroRNA expression patterns in osteosarcoma 93
Embryonic extracellular matrix adsorbed in vivo onto microcarriers induces phenotypic expression in cultured neural crest cells 93
Hyaluronan-CD44 interaction hampers migration of osteoclast-like cells by down-regulating MMP9 91
MicroRNA cloning and sequencing in osteosarcoma cell lines: Differential role of miR-93 91
Bidirectional induction of the cognate receptor-ligand α4/VCAM-1 pair defines a novel mechanism of tumor intravasation 91
CAFCA - A novel centrifugal assay for fluorescence-based cell adhesion for the quantitative analysis of cell-cell and cell-substratum adhesion of freshly isolated normal and tumor leukocytes. 90
An intimate interplay between precocious, migrating pericytes and endothelial cells governs human fetal brain angiogenesis 90
Fluorescence assays to study cell adhesion and migration in vitro 89
INTEGRATION OF CLINICAL, HISTOPATHOLOGICAL, RADIOLOGICAL AND BIOMOLECULAR DATA FOR PREDICTION OF ORAL CANCER RECURRENCE: THE NEOMARK PROJECT'S FIRST REPORT. 89
Tumour dormancy induced by overexpression of PG-M/versican G1 domain in soft tissue sarcomas 89
Fluorescence-based assays for in vitro analysis of cell adhesion and migration 89
Use of phage display technique for identifying peptides capable of binding progenitor/stem cells, peptides thereby obtained and uses thereof 89
Stimulation of initial neural crest cell migration in the axolotl embryo by tissue grafts and extracellular matrix transplanted on microcarriers 88
Matrix-matrix interactions of cartilage oligomeric matrix protein and fibronectin 87
NG2, expressed by immune and neural cells, displays multiple roles in development of experimental autoimmune encephalomyelitis 86
A novel diagnostic marker capable of distinguishing malignant papillary carcinoma from focal and diffuse benign hyperplasia 86
Collagen type VI in neural crest development: distribution in situ and interaction with cells in vitro 85
Identification of pigment cells during early amphibian development (Triturus alpestris, Ambystoma mexicanum) 85
Totale 11.811
Salva come PNG Salva come JPEG
Categoria #
all - tutte 76.676
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 76.676
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202183 0 0 0 0 0 0 0 0 0 0 63 20
2021/2022771 8 17 7 22 15 15 51 109 39 57 79 352
2022/20233.042 422 284 136 229 247 320 13 195 1.049 23 104 20
2023/20241.085 66 101 41 27 122 223 41 76 30 79 58 221
2024/20253.872 89 252 262 194 478 385 129 107 549 397 282 748
2025/20267.744 620 844 902 675 1.180 386 894 337 1.051 563 292 0
Totale 20.415